Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.

NY Retina, a newly launched ophthalmology practice, is set to open March 20 in a newly purchased medical office building in ...

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...

The US Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

Wet AMD in its early stages can be treated with drugs to reduce the formation of new blood vessels, but this treatment is inefficient in cases where blood vessel formation is already in its advanced ...

New research shows that eating this tasty snack daily can help protect against the leading cause of vision loss in older ...

UAB ophthalmology professor awarded prestigious award for vision research in diabetic retinopathy and macular degeneration ...

Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...